STOCK TITAN

Acadia Healthcare (ACHC) CFO awarded 58,799-share equity grant, now holds 107,244 shares

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

YOUNG TODD S. reported acquisition or exercise transactions in this Form 4 filing.

Acadia Healthcare Company, Inc. Chief Financial Officer Todd S. Young reported a compensation-related equity grant of 58,799 shares of common stock on April 10, 2026. The shares were granted at no cash cost to him and are scheduled to vest over three years in equal yearly installments beginning on April 10, 2027. After this award, he directly holds a total of 107,244 common shares, showing this is a sizable but routine stock-based compensation grant rather than an open-market purchase.

Positive

  • None.

Negative

  • None.
Insider YOUNG TODD S.
Role Chief Financial Officer
Type Security Shares Price Value
Grant/Award Common Stock 58,799 $0.00 $0.00
Holdings After Transaction: Common Stock — 107,244 shares (Direct)
Footnotes (1)
  1. F1. Shares will vest over a 3-year period in equal yearly installments beginning April 10, 2027.
Equity grant size 58,799 shares Common stock grant to CFO on April 10, 2026
Holdings after transaction 107,244 shares CFO direct common stock holdings following grant
Grant price per share $0.0000 per share Indicates compensation-related award, not market purchase
Vesting period 3 years Equal yearly installments starting April 10, 2027
Grant, award, or other acquisition financial
"transaction_code_description: Grant, award, or other acquisition"
vesting financial
"Shares will vest over a 3-year period in equal yearly installments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
Form 4 regulatory
"INSIDER FILING DATA (Form 4)"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did ACHC CFO Todd S. Young report?

Todd S. Young reported receiving 58,799 shares of Acadia Healthcare common stock as a compensation-related equity grant. The shares were awarded at no cash cost and increase his direct holdings to 107,244 shares after the transaction, according to the Form 4 filing.

Was the ACHC CFO’s April 2026 transaction a stock purchase or a grant?

The April 10, 2026 transaction for ACHC’s CFO was a stock grant, not an open-market purchase. The Form 4 lists transaction code “A” for a grant, award, or other acquisition, with a price of $0.0000 per share, indicating compensation-related equity rather than a market trade.

How many ACHC shares does the CFO hold after this Form 4 filing?

After the reported grant, ACHC’s CFO Todd S. Young directly holds 107,244 shares of common stock. This total includes the newly awarded 58,799 shares, reflecting his updated equity stake disclosed in the Form 4 following the April 10, 2026 grant transaction.

How will the 58,799-share ACHC grant to the CFO vest over time?

The 58,799-share grant to ACHC’s CFO will vest over a three-year period. According to the footnote, the shares vest in equal yearly installments, with the first installment scheduled to vest on April 10, 2027, and additional installments each year thereafter.

What does transaction code “A” mean in the ACHC CFO Form 4?

Transaction code “A” on the ACHC CFO Form 4 indicates a grant, award, or other acquisition of stock, typically as compensation. It shows the shares were not bought or sold on the open market but awarded directly, with the filing also reporting a per-share price of $0.0000.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
YOUNG TODD S.

(Last)(First)(Middle)
4020 ASPEN GROVE DRIVE, SUITE 900

(Street)
FRANKLIN TENNESSEE 37067

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Acadia Healthcare Company, Inc. [ ACHC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Financial Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/10/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock04/10/2026A58,799(1)A$0107,244D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Shares will vest over a 3-year period in equal yearly installments beginning April 10, 2027.
/s/ Brian Farley as Attorney in Fact for Todd S. Young04/13/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)